Curcuma Longa (curcumin) decreases in vivo cisplatin-induced ototoxicity through heme oxygenase-1 induction

Otology and Neurotology

Volumn 35, Issue 5, 2014, Pages

  Fetoni, Anna R ^a   Eramo, Sara L M ^a   Paciello, Fabiola ^a   Rolesi, Rolando ^a   Podda, Maria Vittoria ^a   Troiani, Diana ^a   Paludetti, Gaetano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Inner ear; Lipid peroxidation; Ototoxicity; Oxidative stress; Prevention

Indexed keywords

CISPLATIN; CURCUMIN; HEME OXYGENASE 1;

ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; EVOKED BRAIN STEM AUDITORY RESPONSE; HEARING LOSS; LIPID PEROXIDATION; LIVER; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; CISPLATIN; CURCUMIN; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HEARING LOSS; HEME OXYGENASE-1; LIPID PEROXIDATION; LIVER; MALE; RATS; RATS, WISTAR;

EID: 84901626102     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000302     Document Type: Article

References (61)

1. Galluzzi L, Senovilla L, Vitale I, et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012;31:1869-83.
2. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007;7:573-84. (Pubitemid 47106628)
3. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 2007;226:157-67. (Pubitemid 46428033)
4. Arslan E, Orzan E, Santarelli R. Global problem of drug-induced hearing loss. Ann N Y Acad Sci 1999;884:1-14.
5. Waissbluth S, Daniel SJ. Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity. Hear Res 2013;299:37-45.
6. Mukherjea D, Rybak LP. Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics 2011;12:1039-50.
7. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today 2005;10:1313-21. (Pubitemid 41416704)
8. U.S. Food and Drug Administration. (2013). www.fda.gov. Accessed April 14, 2013.
9. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?. J Natl Cancer Inst 2008; 100: 773-83. (Pubitemid 351809666)
10. Rybak LP, Mukherjea D, Jajoo S, Ramkumar V. Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies. Tohoku J Exp Med 2009;219:177-86.
11. Goel A, Aggarwal BB. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 2010;62:919-30.
12. Shen M, Chan TH, Dou QP. Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization. Anticancer Agents Med Chem 2012;12:891-901.
13. Zlotogorski A, Dayan A, Dayan D, Chaushu G, Salo T, Vered M. Nutraceuticals as new treatment approaches for oral cancerYI. Curcumin Oral Oncol 2013;49:187-91.
14. Park W, Amin AR, Chen ZG, Shin DM. New perspectives of curcumin in cancer prevention. Cancer Prev Res (Phila) 2013;6: 387-400.
15. Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 2008;10:511-45.
16. Zhou H, Beevers CS, Huang S. Targets of curcumin. Curr Drug Targets 2011;12:332-47.
17. Shishodia S. Molecular mechanisms of curcumin action: gene expression. Biofactors 2013;39:37-55.
18. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 2013;15:195-218.
19. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 2010;80:1895-903.
20. Wang YF, Gu YT, Qin GH, Zhong L, Meng YN. Curcumin ameliorates the permeability of the blood-brain barrier during hypoxia by upregulating heme oxygenase-1 expression in brain microvascular endothelial cells. J Mol Neurosci 2013;51:344-51.
21. Haines DD, Lekli I, Teissier P, Bak I, Tosaki A. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol (Oxf) 2012;204:487-501.
22. Kim HJ, So HS, Lee JH, et al. Heme oxygenase-1 attenuates the cisplatin-induced apoptosis of auditory cells via down-regulation of reactive oxygen species generation. Free Radic Biol Med 2006; 40:1810-9.
23. Kalkanis JG, Whitworth C, Rybak LP. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 2004;114:538-42. (Pubitemid 38391921)
24. Bielefeld EC, Tanaka C, Chen GD, et al. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect. Anticancer Drugs 2013;24:43-51.
25. Wang J, Faulconbridge LRV, Fetoni A, Guitton MJ, Pujol R. Puel JL. Local application of sodium thiosulfate prevents cisplatininduced hearing loss in the guinea pig. Neuropharmacology 2003; 45:380-93. (Pubitemid 36836134)
26. Fetoni AR, De Bartolo P, Eramo SL, et al. Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defense. J Neurosci 2013;33:4011-23.
27. Fetoni AR, Mancuso C, Eramo SLM, et al. In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig. Neuroscience 2010;169:1575-88.
28. Podda MV, Leone L, Piacentini R, Cocco S, Mezzogori D, D'Ascenzo M, Grassi C, et al. Expression of olfactory-type cyclic nucleotide-gated channels in rat cortical astrocytes. Glia 2012;60: 1391-405.
29. Fetoni AR, Troiani D, Eramo SL, Rolesi R, Paludetti G. Efficacy of different routes of administration for Coenzyme Q10 formulation in noise-induced hearing loss: systemic versus transtympanic modality. Acta Otolaryngol 2012a;132:391-9.
30. Qu J, Li X, Wang J, Mi W, Xie K, Qiu J. Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress. Int J Pediatr Otorhinolaryngol 2012;76:111-5.
31. Fetoni AR, Quaranta N, Marchese R, Cadoni G, Paludetti G, Sergi B. The protective role of tiopronin in cisplatin ototoxicity in Wistar rats. Int J Audiol 2004a;43:465-70. (Pubitemid 39472940)
32. Fetoni AR, Sergi B, Ferraresi A, Paludetti G, Troiani D. Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity. Acta Otolaryngol 2004b;124:421-6. (Pubitemid 38797598)
33. Minami SB, Sha SH, Schacht J. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hear Res 2004;198:137-43. (Pubitemid 39536163)
34. Sha SH, Taylor R, Forge A, Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 2001;155:1-8. (Pubitemid 32401586)
35. Deavall DG, Martin EA, Horner JM, Roberts R. Drug-induced oxidative stress and toxicity. J Toxicol 2012;2012:645460.
36. Schacht J, Talaska AE, Rybak LP. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken) 2012;295:1837-50.
37. Fetoni AR, Eramo SL, Rolesi R, Troiani D, Paludetti G. Antioxidant treatment with coenzyme Q-ter in prevention of gentamycin ototoxicity in an animal model. Acta Otorhinolaryngol Ital 2012b;32:103-10.
38. Sandur SK, Ichikawa H, Pandey MK, et al. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 2007;43:568-80. (Pubitemid 47058232)
39. Sánchez Y, Simon GP, Calviño E, de Blas E, Aller P. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. J Pharmacol Exp Ther 2010;335:114-23.
40. Han X, Xu B, Beevers CS, et al. Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis 2012;33:868-75.
41. Scapagnini G, Colombrita C, Amadio M, et al. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid Redox Signal 2006;8:395-403. (Pubitemid 43741311)
42. Sharma S, Ying Z, Gomez-Pinilla F. A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma. Exp Neurol 2010;226:191-9.
43. Guerra-Araiza C, Alvarez-Mejía AL, Sánchez-Torres S, et al. Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases. Free Radic Res 2013;47:451-62.
44. Speciale A, Chirafisi J, Saija A, Cimino F. Nutritional antioxidants and adaptive cell responses: an update. Curr Mol Med 2011;11:770-89.
45. Kim SJ, Park C, Han AL, et al. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells. Hear Res 2009;251:70-82.
46. Gao SS, Choi BM, Chen XY, et al. Kaempferol suppresses cisplatininduced apoptosis via inductions of heme oxygenase-1 and glutamatecysteine ligase catalytic subunit in HEI-OC1 cell. Pharm Res 2010; 27:235-45.
47. Choi BM, Lim DW, Lee JA, Gao SS, Kwon DY, Kim BR. Luteolin suppresses cisplatin-induced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression. J Med Food 2008;11:230-6. (Pubitemid 351948178)
48. Mancuso C, Barone E. The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr Drug Metab 2009;10:579-94.
49. Scapagnini G, Vasto S, Nader AG, Calogero C, Zella D, Galvano F. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011;44:192-201.
50. So H, Kim H, Kim Y, et al. Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1. J Assoc Res Otolaryngol 2008;9:290-306.
51. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011;10:12.
52. Baumeister P, Reiter M, Harréus U. Curcumin and other polyphenolic compounds in head and neck cancer chemoprevention. Oxid Med Cell Longev 2012;2012:902716.
53. Duarte VM, Han E, Veena MS, et al. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKA protein of the NFJB pathway. Mol Cancer Ther 2010;9:2665-75.
54. Mansour HH, Hafez HF, Fahmy NM. Silymarin modulates cisplatininduced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol 2006;39:656-61. (Pubitemid 44892889)
55. Waseem M, Kaushik P, Parvez S. Mitochondria-mediated mitigatory role of curcumin in cisplatin-induced nephrotoxicity. Cell Biochem Funct 2013;31:678-84.
56. Waseem M, Parvez S. Mitochondrial dysfunction mediated cisplatin induced toxicity: modulatory role of curcumin. Food Chem Toxicol 2013;53:334-42.
57. Jamesdaniel S, Manohar S, Hinduja S. Is S-nitrosylation of cochlear proteins a critical factor in cisplatin-induced ototoxicity?. Antioxid Redox Signal 2012;17:929-33.
58. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factorkappaB signaling. Int J Cancer 2004;112:1086. (Pubitemid 39507022)
59. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005;41:1955-68. (Pubitemid 41557681)
60. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1966;50:219-44.
61. Langer T, am Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O. Understanding platinum-induced ototoxicity. Trends Pharmacol Sci 2013;34:458-69.